In hepatocarcinogenesis induced by diethylnitrosamine (DEN) in B6C3F1 mice, the BrafV637E mutation, corresponding to the human BRAFV600E mutation, plays a pivotal role. The livers of transgenic mice with a hepatocyte-specific human BRAFV600E mutation weighed 4.5 times more than that of normal mice and consisted entirely of hepatocytes, resembling DEN-induced preneoplastic hepatocytes. However, these transgenic mice spontaneously died 7 wk after birth, therefore this study aimed to clarify the causes of death. In the transgenic mice, the liver showed thrombopoietin (TPO) overexpression, which is associated with eventual megakaryocytosis and thrombocytosis, and activated platelets were deposited in hepatic sinusoids. TPO was also overexpressed in the DENinduced hepatic tumors, and sinusoidal platelet deposition was observed in the hepatic tumors of humans and mice. Podoplanin was expressed in some of the Kupffer cells in the liver of the transgenic mice, indicating that platelet activation occurred via the interaction of podoplanin with C-type lectin receptor 2 (CLEC-2) on the platelet membrane.
| INTRODUC TI ON
Hepatocarcinogenesis starts with the generation of carcinogenically altered hepatocytes. Following liver damage caused by chronic viral hepatitis, metabolic steatosis, or alcohol-induced injury, carcinogenically altered hepatocytes are forced to expand by the cytokine, chemokine, and growth factor milieu derived from chronic hepatic injury, inflammation, and restorative proliferation, resulting in the formation of preneoplastic nodules from which early hepatocellular carcinomas (HCCs) initiate, eventually leading to progressed and advanced HCC. 1 The mouse model of hepatic tumor induced by neonatal treatment with diethylnitrosamine (DEN) has been often used for investigation of hepatocarcinogenesis. 2 In this model, carcinogenically altered preneoplastic hepatocytes emerged at the earliest stage and eventually progressed into preneoplastic foci, adenomas, and HCC. 3 The carcinogenic process is driven by either an H-ras or a Braf mutation. [4] [5] [6] The role of the mutation is dependent on the animal's genetic background: in hepatocarcinogenesis-sensitive C3H mice, the H-ras codon 61 mutation is prevalent, while in hepatocarcinogenesis-resistant C57BL/6 (B6) mice, the BrafV637E mutation is preferentially selected. 7 We have previously reported that Albumin-Cre-recombinase (Alb-Cre)/BRAFV600E transgenic mice that express the human BRAFV600E mutation, corresponding to the mouse BrafV637E mutation, specifically in hepatocytes from the B6 mouse genetic background showed a marked increase in liver size (four-to five-fold larger liver/body weight ratio than normal mice), and the liver consisted entirely of hepatocytes that resembled DEN-induced preneoplastic hepatocytes. 8 This model therefore enabled us to investigate biological events that occurred within the early preneoplastic lesions induced by neonatal treatment with DEN. However, although these mice were healthy at birth, they spontaneously died at 7 wk of age due to unknown reason(s).
In this study, we aimed to clarify the cause of death in the BRAFV600E transgenic mice by analyzing the blood and tissue specimens isolated from the transgenic mice. Our current findings showed that the hepatocytes in Alb-Cre/BRAFV600E transgenic mice overproduced thrombopoietin (TPO), and this overproduction eventually resulted in megakaryocytosis and thrombocytosis; platelets were activated in the peripheral blood; and large numbers of platelets were deposited in liver sinusoids. Furthermore, podoplanin, which can activate platelets via C-type lectin receptor 2 (CLEC-2) on the platelet membrane, [9] [10] [11] was expressed in some of the Kupffer cells in the liver of Alb-Cre/BRAFV600E transgenic mice. Additionally, these mice showed erythrocyte dyscrasia, glomerulonephropathy, and interstitial pneumonia, which were thought to be derived from the deposition of aberrantly activated platelets. Our data suggested that the TPO-mediated macroenvironmental changes involving the liver and bone marrow may promote proliferation of the BRAFV600E-mutated hepatocytes, but cause hematological, renal, and pulmonary disorders that lead to death.
| MATERIAL S AND ME THODS

| Experimental animals
Male Alb-Cre/BRAFV600E transgenic (5-13 wk of age), and agematched control BRAFV600E and C57BL/6 mice (Charles River Japan) were used in this study. 
| Human materials
Paraffin-embedded human hepatic tumor materials taken from patients who received hepatic biopsy or hepatectomy surgery during 2015-2018 in the affiliated hospital of Asahikawa Medical University were collected. All patients gave informed consent, and the study was approved by the ethical committee at the hospital.
| Antibodies
The antibodies used were against CD31 (Novus), CD61 (Cell Signaling), F4/80 (R&D Systems), podoplanin (R&D Systems), TPO (LSBio), Stat3 (Cell Signaling), S727 phospho-Stat3 (Cell Signaling), Y705 phospho-Stat3 (Cell Signaling) and α-tubulin (Novus).
| Hematological analysis
Complete blood count analyses were performed using an automated hematology analyzer (Sysmex). Peripheral blood and bone marrow smear samples were processed for May-Giemsa staining and examined under a microscope.
| Hepatocyte culture
Hepatocytes were isolated by collagenase perfusion from AlbCre/BRAFV600E and normal B6 mice at the age of 8 wk, purified by low speed centrifugation and cultured in Williams' E medium supplemented with 10% fetal bovine serum and antibiotics for 12 h, followed by incubation with serum-free Williams' E medium for 24 h to collect the conditioned medium.
| Enzyme-linked immunosorbent assay
Platelet factor 4 (PF4) and TPO levels were analyzed using enzymelinked immunosorbent assay kits (R&D Systems) according to the manufacturer's instructions.
| Real-time quantitative reverse transcription (qRT)-polymerase chain reaction (PCR)
RNA was extracted from liver tissue using an RNeasy Mini Kit (Qiagen). cDNA was reverse-transcribed from RNA using a highcapacity cDNA reverse transcription kit (Thermo Fisher). The expression levels of mouse TPO mRNA were then analyzed using a real-time PCR system (Thermo Fisher) with the TaqMan probe for mouse TPO mRNA (Thermo Fisher). mRNA expression was normalized to 18S rRNA expression.
| Western blotting
Tissue samples were lysed in RIPA buffer, separated by polyacryla- 
| Histopathology, immunohistochemistry, and immunofluorescence
Tissues were fixed in 10% formalin in phosphate-buffered saline (PBS), paraffin-embedded and stained with hematoxylin and eosin (H&E).
For live mice, the liver was perfused with PBS via the portal vein at 2-3 mL/min under ether anesthesia, followed by perfusion-fixation with 10% formalin in PBS. For immunohistochemistry, after deparaffinization, rehydration, and antigen retrieval, the tissue sections were incubated with the primary antibodies, followed by incubation with an HRP-conjugated anti-mouse or anti-rabbit IgG secondary antibody 
| Electron microscopy
Renal tissues were fixed with a cacodylate-buffered glutaraldehyde solution followed by osmic acid fixation, dehydration, epoxy resin embedding, and ultrathin sectioning. The sections were examined using an electron microscope (JEOL).
| Statistics
The differences in the experimental values of Alb-Cre/BRAFV600E transgenic mice and those of control BRAFV600E or normal B6 mice were statistically analyzed using Student's paired t test or the chisquared test. caused by red blood cell destruction as well as hematuria derived from glomerulonephropathy as described below ( Figure 2J ). Because schizocytes are generated in association with thrombotic microangiopathy characterized by aberrant platelet activation and formation of fibrin mesh within blood, 12 we investigated the plasma levels of PF4, which is released from α-granules in association with platelet activation. 13 The PF4 levels were elevated in most Alb-Cre/BRAFV600E transgenic mice ( Figure 2K ).
| RE SULTS
| Spontaneous death and hematological changes in the
| TPO overproduction in the liver of Alb-Cre/ BRAFV600E transgenic mice
Thrombopoietin stimulates the differentiation of megakaryocytes from hematopoietic stem cells and the generation of platelets 
| Podoplanin-positive Kupffer cells in the liver of Alb-Cre/BRAFV600E transgenic mice
The interaction of podoplanin with CLEC-2 on platelet membranes is an important mechanism to reciprocally activate platelets and the podoplanin-expressing cells. Figure 5A-H) . In addition, necrotic foci of 1-2 mm in diameter were observed in the liver of some Alb-Cre/BRAFV600E transgenic mice, presumably due to thrombotic embolization in the hepatic vessels ( Figure 6M,N) , but not in normal mice (data not shown). Although the degree of histopathological change in the kidney, lung, and liver was diverse in individual
Alb-Cre/BRAFV600E transgenic mice, and changes tended to become more severe with age. These histopathological changes, however, were not observed in the control BRAFV600E mice or the normal B6 mice.
There were no remarkable histological changes in other organs or tissues in the Alb-Cre/BRAFV600E transgenic mice (data not shown).
| Effect of Asp on the platelet activation/ deposition and histopathological changes
We then investigated whether Asp, an inhibitor of platelet activation via cyclooxygenase inhibition, 25 can reduce platelet activation/ deposition and ameliorate the histopathological changes in Alb-Cre/ 
| Overexpression of TPO in DEN-induced hepatic tumors and platelet deposition in sinusoids in hepatic tumors of human and mice
We lastly investigated whether TPO overproduction and platelet deposition in the sinusoids are also observed in DEN-induced hepatic tumors collected 6-12 mo after neonatal DEN treatment.
As shown in Figure 8A , TPO protein levels were higher in the DEN-induced hepatic tumors compared with the surrounding normal hepatic tissues. Additionally, platelets were adhered to the 
| D ISCUSS I ON
In the present study, we found that mouse hepatocytes expressing the human BRAFV600E mutation, corresponding to the mouse BrafV637E mutation that is highly prevalent in DEN-induced hepatic tumors, 8 overproduced TPO, which led to megakaryocytosis and thrombocytosis, and that large numbers of platelets were deposited on hepatic sinusoids. TPO overproduction and sinusoidal platelet deposition were also observed in DEN-induced hepatic tumors, indicating that the observed phenomena in the Alb-Cre/BRAFV600E transgenic mice reflected the properties of DEN-induced hepatic tumors. Furthermore, sinusoidal platelet deposition was commonly seen in human dysplastic nodules and well differentiated HCC. This study suggested that thrombocytosis, platelet activation, and interaction of platelets to sinusoidal cells promotes hepatocarcinogenesis from an early stage via TPO overproduction by preneoplastic/neoplastic hepatocytes. These results are consistent with previous reports that HCC patients occasionally present thrombocytosis, which is correlated with an unfavorable prognosis, when TPO is overproduced by HCC cells. [26] [27] [28] Thrombopoietin production by hepatocytes is enhanced by transcriptional activation of the TPO gene via the Stat3 pathway. 15, 16 In our present study, we found that Stat3 was hyperphosphorylated, as observed in the DEN-induced hepatic tumors. 17 Although the exact The factors derived from both platelets and platelet-activated sinusoidal cells can stimulate various intracellular signaling pathways in hepatocytes, including the NF-κB, Stat3, MAPK/ERK and PI3K/ Akt pathways. 18, 19 The sinusoidal platelet deposition indicated that platelets contribute to hepatocyte proliferation in the Alb-Cre/ BRAFV600E transgenic mice as well as in hepatic tumor cells.
In the Alb-Cre/BRAFV600E transgenic mice, platelets were thought to be activated in the peripheral blood because plasma PF4 levels were elevated and because some of the platelets were increased in size, which is the characteristic feature of activated platelets. 34 Conversely, schizocytes were observed in the peripheral blood smear samples, indicating that erythrocytes were damaged. Aberrant platelet activation causes thrombotic microangiopathy, which leads to erythrocyte dyscrasia. 12 However, the platelet numbers are usually decreased in thrombotic microangiopathy, 12 and the TPO levels are commonly decreased in association with thrombocytosis because TPO is bound to the platelet c-Mpl receptor, internalized, and destroyed. 35 In the Alb-Cre/ BRAFV600E transgenic mice, however, continuous TPO overproduction by BRAFV600E-mutated hepatocytes might maintain the high circulating TPO levels and increase the number of platelets.
In the liver of Alb-Cre/BRAFV600E transgenic mice, some Kupffer cells were positive for podoplanin. In these physiological conditions, activated macrophages such as those treated with thioglycollate or lipopolysaccharide in vitro, 21 in those found in the liver of Salmonellainfected mice, 22 in those found in the spleen and peritoneal cavity in zymosan-treated mice 23 and in severe atherosclerotic lesions in humans. 24 It is thought that, in the hepatic microenvironment of AlbCre/BRAFV600E transgenic mice, a subset of resident macrophages or those recruited from outside of the liver might be influenced to express podoplanin.
In In the Alb-Cre/BRAFV600E transgenic mice, Asp, a platelet activation inhibitor via cyclooxygenase inhibition, 25 efficiently prevented platelet activation and ameliorated the histopathological changes in association with decreased platelet deposition in the liver, kidney, and lung. These observations indicate that the pathological changes in these organs are dependent on the deposition of aberrantly activated platelets. Interestingly, the liver/body weight ratio was decreased to 70% in the Asp-treated Alb-Cre/BRAFV600E transgenic mice, and normal-looking hepatocyte areas were specifically observed together with small basophilic hepatocytes. Furthermore, the degree of sinusoidal platelet deposition was lower in the normal-looking hepatocyte areas than in the small basophilic hepatocyte areas. These observations suggested that the properties of BRAFV600E-mutated hepatocytes were regulated by sinusoidal platelet deposition.
In conclusion, the macroenvironment that results from TPO overproduction by the preneoplastic/neoplastic hepatocytes, eventual megakaryocytosis/thrombocytosis, and platelet activation and interaction with hepatic sinusoidal cells may contribute to hepatocarcinogenesis from a very early stage. However, erythrocyte dyscrasia, presumably due to thrombotic microangiopathy, and glomerulonephropathy/interstitial pneumonia due to platelet deposition caused spontaneous death.
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